In this context, pharmacological targeting of LONP1 may represent an intriguing and unexplored way to indirectly impact on CI stability and consequently cancer cell metabolism, also considering that the protease inhibition has been found effective to selectively induce apoptosis in cancer cells [55]. The gene discussed is LONP1; the disease is cancer.